James Stevenson

Cleveland Clinic — United States

Medicine · Health Sciences

48h-index14.9kcitations225works28.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(75), Lung Cancer Diagnosis and Treatment(47), Cancer Immunotherapy and Biomarkers(37), Lung Cancer Research Studies(34), Occupational and environmental lung diseases(29)

Publications225 total

Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study
Lung Cancer·2025· 1 cited
P1.11.77 A Comprehensive Analysis of Front-Line Regimens for Stage IV Non-Squamous Non-Small Cell Lung Cancer: A 13-Year Experience
Journal of Thoracic Oncology·2025
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC)
Clinical Lung Cancer·2025
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025
Journal of the National Comprehensive Cancer Network·2025· 15 cited
Impact of Social Determinants on Melanoma Outcomes in Canada: A Single‐Centre Retrospective Study
Journal of Surgical Oncology·2025Open Access
Synthesis of Psilocin, Psilocybin and 5‐MeO‐DMT Succinate, All Labelled With Carbon‐14 at the Indole 2‐Position
Journal of Labelled Compounds and Radiopharmaceuticals·2025
Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network·2025· 11 cited
Radiomic signatures as predictors of pathological response to neoadjuvant chemoimmunotherapy in surgically resected NSCLC.
Journal of Clinical Oncology·2025
Exploring the evolving therapeutic landscape of stage IV lung squamous cell carcinoma: A 13-year single center experience.
Journal of Clinical Oncology·2025
Association of radiomic features with disease-free survival following neoadjuvant chemoimmunotherapy in resectable NSCLC.
Journal of Clinical Oncology·2025
Real world analysis comparing chemoradiation with durvalumab vs chemoradiation alone in locally advanced, unresectable, stage III non-small cell lung cancer.
Journal of Clinical Oncology·2025
Long-Term Outcomes of Extensive-Stage Small Cell Lung Cancer Treated with Chemotherapy or Chemo-Immunotherapy: A Propensity Score Adjusted Cohort Study
SSRN Electronic Journal·2025Open Access
A Rare Case of Scrotal Swelling: Prostate Cancer Metastasis Masquerading as a Complicated Hydrocele
Cureus·2024Open Access
ASO Visual Abstract: Are Positive Biopsy Margins in Melanoma Significant? A Cohort Study of Micro- Versus Macroscopic Margin Status and Their Impact on Residual Disease and Survival
Annals of Surgical Oncology·2024
Are Positive Biopsy Margins in Melanoma Significant?: A Cohort Study of Micro- Versus Macroscopic Margin Status and Their Impact on Residual Disease and Survival
Annals of Surgical Oncology·2024· 4 cited
EP.12H.01 A Phase 2 Study to Assess BDTX-1535, An Oral EGFR Inhibitor, in Patients with Non-Small Cell Lung Cancer
Journal of Thoracic Oncology·2024· 3 citedOpen Access
Demographic Disparities in Lung Cancer Mortality and Trends in the United States From 1999 Through 2020: A Population-Based CDC Database Analysis
Journal of the National Comprehensive Cancer Network·2024· 12 cited
Survival outcomes of patients with extensive-stage small cell lung cancer who received treatment with atezolizumab in combination with carboplatin and etoposide: A propensity score adjusted cohort study.
Journal of Clinical Oncology·2024· 1 cited
Effect of tumor burden on survival in patients with stage IV <i>EGFR</i>-mutant NSCLC receiving osimertinib monotherapy.
Journal of Clinical Oncology·2024
Non–Small Cell Lung Cancer, Version 4.2024
Journal of the National Comprehensive Cancer Network·2024· 617 cited
page 1 of 12Next →

Frequent Co-authors

Matthew A. Gubens(14), Corey J. Langer(11), Stephen M. Hahn(10), Hossein Borghaei(9), David S. Ettinger(9), Douglas E. Wood(9), Lucian R. Chirieac(9), Rudy P. Lackner(9), Michael Lanuti(9), Jules Lin(9), Billy W. Loo(9), Gregory J. Riely(9), Theresa A. Shapiro(9), Stephen C. Yang(9), Shirish M. Gadgeel(8), Thomas J. Dilling(8), Gregory A. Otterson(8), Steven E. Schild(8), Kristina M. Gregory(8), Miranda Hughes(8)